Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T15:06:42.369Z.
Calculation as of: 2026-10-06T15:06:42.369Z.
Quote observation: 2026-10-06T15:05:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$132.67M
Price/OCF Ratio
N/A
TTM Avg
66.43
3Y Avg
66.43
5Y Avg
66.43
Market Cap
$136.65M
Price/OCF Ratio
98.24
TTM Avg
456.46
3Y Avg
456.46
5Y Avg
456.46
Market Cap
$129.68M
Price/OCF Ratio
4.59
TTM Avg
39.51
3Y Avg
39.66
5Y Avg
39.66
Market Cap
$139.73M
Price/OCF Ratio
1.11
TTM Avg
4.90
3Y Avg
4.90
5Y Avg
4.90
Market Cap
$142.15M
Price/OCF Ratio
111.32
TTM Avg
51.49
3Y Avg
30.98
5Y Avg
26.48
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $133.72M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $132.67M | N/A | 66.43 | 66.43 | 66.43 |
| LifeMD, Inc. (LFMD)vs › | $135.66M | N/A | 20.60 | 44.02 | 44.02 |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | 98.24 | 456.46 | 456.46 | 456.46 |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 4.59 | 39.51 | 39.66 | 39.66 |
| Entera Bio Ltd. (ENTX)vs › | $127.91M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 1.11 | 4.90 | 4.90 | 4.90 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | 111.32 | 51.49 | 30.98 | 26.48 |
| Nyxoah S.A. (NYXH)vs › | $142.60M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
